This is the authors' abstract. We don't add key points for this paper.
Albumin is obtainable from human blood plasma by an ion exchange chromatographic procedure in a yield of about 95% and a purity well above Pharmacopoeia requirements. Cryosupernatant, factor IX depleted plasma is precipitated with 12 and 25% w/v polyethylene glycol 4000. The second precipitate is dissolved to 8% w/v protein and applied to a DEAE-Sephadex A-50 or a DEAE-Sepharose CL-6B column. Albumin is further purified by chromatography on SP-Sephadex C-50. Gel filtration on Sephadex G-25 is used for desalting prior to lyophilization. The process has been initially designed for fractionation of 50 litres plasma/week but can be further scaled up to meet considerably higher capacity requirements.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Curling et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: